BioCatalyst

BMEA — Biomea Fusion, Inc. catalysts

1 verified catalyst event(s) for Biomea Fusion, Inc. (ticker BMEA). Each is linked to its official source. Verified as of 2026-10-30.

Next verified catalyst

2027-03-01 — Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Gly · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-03 (month)
in 4mo
ESTIMATED
 READOUT
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Ach
Phase 2 · Type 2 Diabetes
 BMEA Biomea Fusion, Inc. icovamenib 100mg ClinicalTrials.gov ↗
✓ Source-checked 2026-10-30
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.